
Kelun-Biotech Announces Breakthrough Therapy Designation Granted For Sacituzumab Tirumotecan (Sac-TMT) In Combination ...
(MENAFN- PR Newswire) CHENGDU, China, June 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) …